{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:07:56Z","timestamp":1791972476950,"version":"4.3.4"},"reference-count":222,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Cancer Investigation"],"published-print":{"date-parts":[[2022,7,3]]},"DOI":"10.1080\/07357907.2022.2055050","type":"journal-article","created":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T16:07:55Z","timestamp":1648051675000},"page":"516-543","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":19,"title":["Signaling Pathways Involved in 5-FU Drug Resistance in Cancer"],"prefix":"10.1080","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2636-9856","authenticated-orcid":false,"given":"Fahima","family":"Danesh Pouya","sequence":"first","affiliation":[{"name":"Department of Biochemistry, School of Medicine, Urmia University of Medical Sciences","place":["Urmia, Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1506-1909","authenticated-orcid":false,"given":"Yousef","family":"Rasmi","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, School of Medicine, Urmia University of Medical Sciences","place":["Urmia, Iran"]},{"name":"Cellular and Molecular Research Center, Urmia University of Medical Sciences","place":["Urmia, Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4262-1636","authenticated-orcid":false,"given":"Mohadeseh","family":"Nemati","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, School of Medicine, Urmia University of Medical Sciences","place":["Urmia, Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,3,28]]},"reference":[{"issue":"2","key":"e_1_3_4_2_1","first-page":"119","article-title":"Studies in 2-acetylaminofluorene carcinogenesis: III. The utilization of uracil-2-C14 by preneoplastic rat liver and rat hepatoma","volume":"14","author":"Rutman RJ","year":"1954","unstructured":"Rutman RJ, Cantarow A, Paschkis KE. Studies in 2-acetylaminofluorene carcinogenesis: III. The utilization of uracil-2-C14 by preneoplastic rat liver and rat hepatoma. Cancer Res. 1954;14(2):119\u2013123.","journal-title":"Cancer Res"},{"key":"e_1_3_4_3_1","volume-title":"Lippincott's illustrated reviews: pharmacology","author":"Howland RD","year":"2006","unstructured":"Howland RD, Mycek MJ, Harvey RA, Champe PC. Lippincott's illustrated reviews: pharmacology. Philadelphia (PA): Lippincott Williams & Wilkins, 2006."},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1804"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.6.2432"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2005.01.047"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198916040-00002"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1074"},{"key":"e_1_3_4_9_1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-1-59259-725-3_3","volume-title":"Antifolate drugs in cancer therapy","author":"Gorlick R","year":"1999","unstructured":"Gorlick R, Bertino JR. Clinical pharmacology and resistance to dihydrofolate reductase inhibitors. In: Jackman AL, editor. Antifolate drugs in cancer therapy. Totowa (NJ): Humana Press, 1999. p. 37\u201357."},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.1041040305"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.2174\/1389201003378979"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1773-2247(09)50005-6"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.19.94"},{"issue":"11","key":"e_1_3_4_14_1","first-page":"4929","article-title":"Effect of intravenous dose and schedule on cerebrospinal fluid pharmacokinetics of 5-fluorouracil in the monkey","volume":"44","author":"Kerr IG","year":"1984","unstructured":"Kerr IG, Zimm S, Collins JM, O'Neill D, Poplack DG. Effect of intravenous dose and schedule on cerebrospinal fluid pharmacokinetics of 5-fluorouracil in the monkey. Cancer Res. 1984;44(11):4929\u20134932.","journal-title":"Cancer Res"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e32833c6107"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers2031717"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00686631"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.15785"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-2960"},{"issue":"3","key":"e_1_3_4_20_1","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0026-895X(25)14548-3","article-title":"The role of deoxyuridine triphosphate nucleotidohydrolase, uracil-DNA glycosylase, and DNA polymerase \u03b1 in the metabolism of FUdR in human tumor cells","volume":"18","author":"Sj C","year":"1980","unstructured":"Sj C, Cheng Y-C. The role of deoxyuridine triphosphate nucleotidohydrolase, uracil-DNA glycosylase, and DNA polymerase \u03b1 in the metabolism of FUdR in human tumor cells. Mol Pharmacol. 1980;18(3):513\u2013520.","journal-title":"Mol Pharmacol"},{"key":"e_1_3_4_21_1","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0026-895X(25)13666-3","article-title":"Mechanisms of excision of 5-fluorouracil by the uracil DNA glycosylase in normal human cells","volume":"43","author":"Mauro DJ","year":"1993","unstructured":"Mauro DJ, De Riel J, Tallarida RJ, Sirover MA. Mechanisms of excision of 5-fluorouracil by the uracil DNA glycosylase in normal human cells. Mol Pharm. 1993;43:854.","journal-title":"Mol Pharm"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdh264"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.77.8.4966"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/0163-7258(90)90056-8"},{"issue":"7","key":"e_1_3_4_25_1","first-page":"1855","article-title":"Novel mechanism (s) of resistance to 5-fluorouracil in human colon cancer (HCT-8) sublines following exposure to two different clinically relevant dose schedules","volume":"52","author":"Aschele C","year":"1992","unstructured":"Aschele C, Sobrero A, Faderan MA, Bertino JR. Novel mechanism (s) of resistance to 5-fluorouracil in human colon cancer (HCT-8) sublines following exposure to two different clinically relevant dose schedules. Cancer Res. 1992;52(7):1855\u20131864.","journal-title":"Cancer Res"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(99)00211-7"},{"issue":"8","key":"e_1_3_4_27_1","first-page":"2203","article-title":"Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile","volume":"47","author":"Heggie GD","year":"1987","unstructured":"Heggie GD, Sommadossi J-P, Cross DS, Huster WJ, Diasio RB. Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile. Cancer Res. 1987;47(8):2203\u20132206.","journal-title":"Cancer Res"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543780902729412"},{"issue":"7","key":"e_1_3_4_29_1","first-page":"2223","article-title":"Pharmacokinetics of 5-fluorouracil administered orally, by rapid intravenous and by slow infusion","volume":"40","author":"Fraile RJ","year":"1980","unstructured":"Fraile RJ, Baker LH, Buroker TR, Horwitz J, Vaitkevicius V. Pharmacokinetics of 5-fluorouracil administered orally, by rapid intravenous and by slow infusion. Cancer Res. 1980;40(7):2223\u20132228.","journal-title":"Cancer Res"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1991.tb27255.x"},{"issue":"9","key":"e_1_3_4_31_1","first-page":"2289","article-title":"The oral fluoropyrimidines in cancer chemotherapy","volume":"5","author":"Lamont EB","year":"1999","unstructured":"Lamont EB, Schilsky RL. The oral fluoropyrimidines in cancer chemotherapy. Clin Cancer Res. 1999;5(9):2289\u20132296.","journal-title":"Clin Cancer Res"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19910801)68:3<499::"},{"issue":"22","key":"e_1_3_4_33_1","first-page":"5433","article-title":"Dihydropyrimidine dehydrogenase activity in human peripheral blood mononuclear cells and liver: population characteristics, newly identified deficient patients, and clinical implication in 5-fluorouracil chemotherapy","volume":"53","author":"Lu Z","year":"1993","unstructured":"Lu Z, Zhang R, Diasio RB. Dihydropyrimidine dehydrogenase activity in human peripheral blood mononuclear cells and liver: population characteristics, newly identified deficient patients, and clinical implication in 5-fluorouracil chemotherapy. Cancer Res. 1993;53(22):5433\u20135438.","journal-title":"Cancer Res"},{"issue":"5","key":"e_1_3_4_34_1","first-page":"270","article-title":"Lethal drug interactions of sorivudine, a new antiviral drug, with oral 5-fluorouracil prodrugs","volume":"25","author":"Okuda H","year":"1997","unstructured":"Okuda H, Nishiyama T, Ogura K, Nagayama S, Ikeda K, Yamaguchi S, et\u00a0al. Lethal drug interactions of sorivudine, a new antiviral drug, with oral 5-fluorouracil prodrugs. Drug Metab Dispos. 1997;25(5):270\u2013273.","journal-title":"Drug Metab Dispos"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-009-1149-8"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.2174\/0929867054864868"},{"issue":"4","key":"e_1_3_4_37_1","first-page":"1322","article-title":"Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase","volume":"6","author":"Salonga D","year":"2000","unstructured":"Salonga D, Danenberg KD, Johnson M, Metzger R, Groshen S, Tsao-Wei DD, et\u00a0al. Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase. Clin Cancer Res. 2000;6(4):1322\u20131327.","journal-title":"Clin Cancer Res"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.10.3223"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.6.1760"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.06.060"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e3282f4aea6"},{"key":"e_1_3_4_42_1","first-page":"63","article-title":"Folate\/vitamin B12 inter-relationships","volume":"28","author":"Scott J","year":"1994","unstructured":"Scott J, Weir D. Folate\/vitamin B12 inter-relationships. Essays Biochem. 1994;28:63\u201372.","journal-title":"Essays Biochem"},{"key":"e_1_3_4_43_1","first-page":"69","article-title":"Methylenetetrahydrofolate reductase","volume":"9028","author":"Mouse H.","year":"2001","unstructured":"Mouse H. Methylenetetrahydrofolate reductase. Databases. 2001;9028:69\u201377.","journal-title":"Databases"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djh015"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1677\/ERC-06-0077"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.10364"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.5.2623"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-1119(02)00398-0"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI0215617"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28429"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0605-595"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1134\/S1990747820020142"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2013.2195"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29923"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1593\/neo.13706"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-018-0587-8"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms161024772"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.acthis.2011.11.010"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v10.i11.1569"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1593\/neo.04571"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M601857200"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.21504"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.24.6.2251-2262.2004"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.22157"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M104431200"},{"issue":"5","key":"e_1_3_4_66_1","first-page":"6203","article-title":"JAB1-STAT3 activation loop is associated with recurrence following 5-fluorouracil-based adjuvant chemotherapy in human colorectal cancer","volume":"14","author":"Kugimiya N","year":"2017","unstructured":"Kugimiya N, Nishimoto A, Hosoyama T, Ueno K, Takemoto Y, Harada E, et\u00a0al. JAB1-STAT3 activation loop is associated with recurrence following 5-fluorouracil-based adjuvant chemotherapy in human colorectal cancer. Oncol Lett. 2017;14(5):6203\u20136209.","journal-title":"Oncol Lett"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.630852"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075788"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1517\/14728222.2012.709238"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1207606"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0487"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.2218"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2017.04.059"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1080\/01635581.2015.1085581"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.04.061"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-008-2252-z"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.2217\/hep-2020-0001"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-13-363"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.907514"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00827"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI3785"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.8.4227"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10499"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.06-6191com"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2002.tb02176.x"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.05.111"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-012-1317-9"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells9102297"},{"issue":"18","key":"e_1_3_4_89_1","first-page":"4236","article-title":"The protein tyrosine phosphatase DEP-1 is induced during differentiation and inhibits growth of breast cancer cells","volume":"56","author":"Keane MM","year":"1996","unstructured":"Keane MM, Lowrey GA, Ettenberg SA, Dayton MA, Lipkowitz S. The protein tyrosine phosphatase DEP-1 is induced during differentiation and inhibits growth of breast cancer cells. Cancer Res. 1996;56(18):4236\u20134243.","journal-title":"Cancer Res"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M403573200"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.3892\/or.2015.3769"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32423"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M413309200"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206122"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0016-5085(03)01064-3"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-018-0004-2"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2017.6295"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00685932"},{"issue":"1","key":"e_1_3_4_99_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep17663","article-title":"Multiple regulation pathways and pivotal biological functions of STAT3 in cancer","volume":"5","author":"Yuan J","year":"2015","unstructured":"Yuan J, Zhang F, Niu R. Multiple regulation pathways and pivotal biological functions of STAT3 in cancer. Sci Rep. 2015;5(1):1\u201310.","journal-title":"Sci Rep"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12015-007-0004-8"},{"key":"e_1_3_4_101_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.cellbio.20.010403.113126"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.1038\/18884"},{"key":"e_1_3_4_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2009.08.001"},{"key":"e_1_3_4_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-386035-4.00002-1"},{"key":"e_1_3_4_105_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrm3470"},{"key":"e_1_3_4_106_1","doi-asserted-by":"publisher","DOI":"10.1093\/abbs\/gmr079"},{"key":"e_1_3_4_107_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800562"},{"key":"e_1_3_4_108_1","doi-asserted-by":"publisher","DOI":"10.2741\/2368"},{"key":"e_1_3_4_109_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.23250"},{"key":"e_1_3_4_110_1","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.1988.supplement_10.4"},{"key":"e_1_3_4_111_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2536800100"},{"key":"e_1_3_4_112_1","doi-asserted-by":"publisher","DOI":"10.1038\/1270"},{"key":"e_1_3_4_113_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.06288-11"},{"key":"e_1_3_4_114_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature11252"},{"key":"e_1_3_4_115_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22046"},{"issue":"20","key":"e_1_3_4_116_1","first-page":"4478","article-title":"Mutations in \u03b2-catenin are uncommon in colorectal cancer occurring in occasional replication error-positive tumors","volume":"57","author":"Kitaeva MN","year":"1997","unstructured":"Kitaeva MN, Grogan L, Williams JP, Dimond E, Nakahara K, Hausner P, et\u00a0al. Mutations in \u03b2-catenin are uncommon in colorectal cancer occurring in occasional replication error-positive tumors. Cancer Res. 1997;57(20):4478\u20134481.","journal-title":"Cancer Res"},{"key":"e_1_3_4_117_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2014.00005"},{"key":"e_1_3_4_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-1119(01)00689-8"},{"key":"e_1_3_4_119_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2271"},{"key":"e_1_3_4_120_1","doi-asserted-by":"publisher","DOI":"10.1038\/nn.3165"},{"key":"e_1_3_4_121_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-015-4674-6"},{"key":"e_1_3_4_122_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-015-2036-9"},{"key":"e_1_3_4_123_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.24133"},{"key":"e_1_3_4_124_1","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-018-0128-8"},{"key":"e_1_3_4_125_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-013-1307-3"},{"key":"e_1_3_4_126_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.14.12.1448"},{"key":"e_1_3_4_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2009.04.012"},{"key":"e_1_3_4_128_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkr697"},{"key":"e_1_3_4_129_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2508"},{"key":"e_1_3_4_130_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28226"},{"key":"e_1_3_4_131_1","doi-asserted-by":"publisher","DOI":"10.1186\/1747-1028-4-8"},{"key":"e_1_3_4_132_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2019.03.017"},{"key":"e_1_3_4_133_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28381"},{"issue":"2","key":"e_1_3_4_134_1","first-page":"53","article-title":"Investigating the methylation status of DACT2 gene and its association with MTHFR C677T polymorphism in patients with colorectal cancer","volume":"8","author":"Jalilvand A","year":"2019","unstructured":"Jalilvand A, Soltanpour MS. Investigating the methylation status of DACT2 gene and its association with MTHFR C677T polymorphism in patients with colorectal cancer. Mol Biol Res Commun. 2019;8(2):53.","journal-title":"Mol Biol Res Commun"},{"key":"e_1_3_4_135_1","doi-asserted-by":"publisher","DOI":"10.5001\/omj.2020.49"},{"issue":"2","key":"e_1_3_4_136_1","first-page":"117","article-title":"Epithelial-mesenchymal transition, the tumor microenvironment, and metastatic behavior of epithelial malignancies","volume":"3","author":"Talbot LJ","year":"2012","unstructured":"Talbot LJ, Bhattacharya SD, Kuo PC. Epithelial-mesenchymal transition, the tumor microenvironment, and metastatic behavior of epithelial malignancies. Int J Biochem Mol Biol. 2012;3(2):117\u2013136.","journal-title":"Int J Biochem Mol Biol"},{"key":"e_1_3_4_137_1","doi-asserted-by":"publisher","DOI":"10.5493\/wjem.v5.i2.84"},{"key":"e_1_3_4_138_1","doi-asserted-by":"publisher","DOI":"10.1089\/jmf.2013.0061"},{"key":"e_1_3_4_139_1","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.407"},{"key":"e_1_3_4_140_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-016-1313-7"},{"key":"e_1_3_4_141_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-015-3673-y"},{"key":"e_1_3_4_142_1","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.7743"},{"key":"e_1_3_4_143_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-019-00781-9"},{"key":"e_1_3_4_144_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.109961"},{"key":"e_1_3_4_145_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209547"},{"key":"e_1_3_4_146_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209556"},{"key":"e_1_3_4_147_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2003.009506"},{"key":"e_1_3_4_148_1","doi-asserted-by":"publisher","DOI":"10.1634\/stemcells.2005-0661"},{"key":"e_1_3_4_149_1","first-page":"44","volume-title":"Semin Cancer Biol","author":"Nejak-Bowen KN","year":"2011","unstructured":"Nejak-Bowen KN, Monga SP. Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad. Semin Cancer Biol. 2011;21(1):44\u201358."},{"key":"e_1_3_4_150_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21832"},{"key":"e_1_3_4_151_1","doi-asserted-by":"publisher","DOI":"10.1016\/0166-3542(94)90058-2"},{"key":"e_1_3_4_152_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605064"},{"key":"e_1_3_4_153_1","doi-asserted-by":"publisher","DOI":"10.1080\/21691401.2018.1453827"},{"key":"e_1_3_4_154_1","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13747"},{"key":"e_1_3_4_155_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2018.3"},{"key":"e_1_3_4_156_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6809"},{"key":"e_1_3_4_157_1","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2017.30"},{"key":"e_1_3_4_158_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2019.05.003"},{"issue":"4","key":"e_1_3_4_159_1","first-page":"1221","article-title":"Alterations of MEN1 and E-cadherin\/\u03b2-catenin complex in sporadic pulmonary carcinoids","volume":"41","author":"Veschi S","year":"2012","unstructured":"Veschi S, Lattanzio R, Aceto GM, Curia MC, Magnasco S, Angelucci D, et\u00a0al. Alterations of MEN1 and E-cadherin\/\u03b2-catenin complex in sporadic pulmonary carcinoids. Int J Oncol Res. 2012;41(4):1221\u20131228.","journal-title":"Int J Oncol Res"},{"key":"e_1_3_4_160_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature21063"},{"key":"e_1_3_4_161_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12020345"},{"key":"e_1_3_4_162_1","doi-asserted-by":"publisher","DOI":"10.1159\/000481887"},{"key":"e_1_3_4_163_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-2570"},{"key":"e_1_3_4_164_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4652(199912)181:3<393::AID-JCP3>3.0.CO;2-6"},{"key":"e_1_3_4_165_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2015.07.048"},{"key":"e_1_3_4_166_1","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12480"},{"key":"e_1_3_4_167_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2011.02154.x"},{"issue":"2","key":"e_1_3_4_168_1","first-page":"151","article-title":"Notch: a key regulator of tumor angiogenesis and metastasis","volume":"27","author":"Garcia A","year":"2012","unstructured":"Garcia A, Kandel JJ. Notch: a key regulator of tumor angiogenesis and metastasis. Histol Histopathol. 2012;27(2):151\u2013156.","journal-title":"Histol Histopathol"},{"key":"e_1_3_4_169_1","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6768942"},{"key":"e_1_3_4_170_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2016.04.011"},{"key":"e_1_3_4_171_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.431"},{"key":"e_1_3_4_172_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-009-9970-0"},{"key":"e_1_3_4_173_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-015-3261-1"},{"issue":"6","key":"e_1_3_4_174_1","first-page":"3272","article-title":"Clinicopathological significance of aberrant Notch receptors in intrahepatic cholangiocarcinoma","volume":"7","author":"Wu W-R","year":"2014","unstructured":"Wu W-R, Shi X-D, Zhang R, Zhu M-S, Xu L-B, Yu X-H, et\u00a0al. Clinicopathological significance of aberrant Notch receptors in intrahepatic cholangiocarcinoma. Int J Clin Exp Pathol. 2014;7(6):3272.","journal-title":"Int J Clin Exp Pathol"},{"key":"e_1_3_4_175_1","doi-asserted-by":"publisher","DOI":"10.3892\/or.2014.3123"},{"key":"e_1_3_4_176_1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a000034"},{"key":"e_1_3_4_177_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2013.01.004"},{"key":"e_1_3_4_178_1","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2010.177"},{"key":"e_1_3_4_179_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.12.012"},{"key":"e_1_3_4_180_1","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-12-86"},{"key":"e_1_3_4_181_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.10.010"},{"key":"e_1_3_4_182_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2011.01088.x"},{"key":"e_1_3_4_183_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.52"},{"key":"e_1_3_4_184_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2010.03.018"},{"key":"e_1_3_4_185_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.01.058"},{"key":"e_1_3_4_186_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI58454"},{"key":"e_1_3_4_187_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.07.009"},{"issue":"4","key":"e_1_3_4_188_1","first-page":"1631","article-title":"NF\u03baB-associated pathways in progression of chemoresistance to 5-fluorouracil in an in\u00a0vitro model of colonic carcinoma","volume":"36","author":"Koerber MI","year":"2016","unstructured":"Koerber MI, Staribacher A, Ratzenb\u00f6ck I, Steger G, Mader RM. NF\u03baB-associated pathways in progression of chemoresistance to 5-fluorouracil in an in\u00a0vitro model of colonic carcinoma. Anticancer Res. 2016;36(4):1631\u20131639.","journal-title":"Anticancer Res"},{"key":"e_1_3_4_189_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-04172-z"},{"key":"e_1_3_4_190_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12013-014-9827-5"},{"key":"e_1_3_4_191_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1291-0"},{"key":"e_1_3_4_192_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-53276-1"},{"key":"e_1_3_4_193_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.10972"},{"key":"e_1_3_4_194_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6606020"},{"key":"e_1_3_4_195_1","doi-asserted-by":"publisher","DOI":"10.3892\/or.2012.2200"},{"key":"e_1_3_4_196_1","doi-asserted-by":"publisher","DOI":"10.3390\/toxins9040119"},{"key":"e_1_3_4_197_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-013-1095-0"},{"key":"e_1_3_4_198_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2008.08.002"},{"key":"e_1_3_4_199_1","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2019.4684"},{"key":"e_1_3_4_200_1","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S118272"},{"key":"e_1_3_4_201_1","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.12252"},{"key":"e_1_3_4_202_1","doi-asserted-by":"publisher","DOI":"10.3109\/00313020903257756"},{"key":"e_1_3_4_203_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-09-0162"},{"key":"e_1_3_4_204_1","doi-asserted-by":"publisher","DOI":"10.1093\/abbs\/gms074"},{"issue":"1","key":"e_1_3_4_205_1","first-page":"159","article-title":"Vitamin K2 augments 5-fluorouracil-induced growth inhibition of human hepatocellular carcinoma cells by inhibiting NF-\u03baB activation","volume":"25","author":"Zhang H","year":"2011","unstructured":"Zhang H, Ozaki I, Hamajima H, Iwane S, Takahashi H, Kawaguchi Y, et\u00a0al. Vitamin K2 augments 5-fluorouracil-induced growth inhibition of human hepatocellular carcinoma cells by inhibiting NF-\u03baB activation. Oncol Rep. 2011;25(1):159\u2013166.","journal-title":"Oncol Rep"},{"key":"e_1_3_4_206_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-017-0098-0"},{"key":"e_1_3_4_207_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1229"},{"key":"e_1_3_4_208_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.938601"},{"key":"e_1_3_4_209_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(00)80094-x"},{"key":"e_1_3_4_210_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2086"},{"key":"e_1_3_4_211_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng1304"},{"key":"e_1_3_4_212_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013054"},{"key":"e_1_3_4_213_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.2216"},{"key":"e_1_3_4_214_1","doi-asserted-by":"publisher","DOI":"10.3109\/03009731003668316"},{"key":"e_1_3_4_215_1","doi-asserted-by":"publisher","DOI":"10.1002\/emmm.200900039"},{"key":"e_1_3_4_216_1","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S71034"},{"key":"e_1_3_4_217_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.310"},{"key":"e_1_3_4_218_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.586"},{"key":"e_1_3_4_219_1","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S139639"},{"key":"e_1_3_4_220_1","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2015.3136"},{"key":"e_1_3_4_221_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0070-2153(03)53002-2"},{"key":"e_1_3_4_222_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgi292"},{"key":"e_1_3_4_223_1","doi-asserted-by":"publisher","DOI":"10.1093\/abbs\/40.9.819"}],"container-title":["Cancer Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/07357907.2022.2055050","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T21:53:48Z","timestamp":1770414828000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/07357907.2022.2055050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,28]]},"references-count":222,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,7,3]]}},"alternative-id":["10.1080\/07357907.2022.2055050"],"URL":"https:\/\/doi.org\/10.1080\/07357907.2022.2055050","relation":{},"ISSN":["0735-7907","1532-4192"],"issn-type":[{"value":"0735-7907","type":"print"},{"value":"1532-4192","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,28]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icnv20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icnv20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-10-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-19","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}